Company intelligence / Profile preview

Innovest

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Innovest Global, Inc. formed a biotechnology and health sciences division headed by Dr. Dwain Morris-Irvin, focusing on neurodegenerative diseases (notably Parkinson’s), brain cancer, and advanced cosmetic biosciences; as of 2019-2020, the division was assembling leadership and an advisory board but no products are reported in clinical development[2][4][6].

Therapeutic areas: OncologyNeurologyDermatology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Innovest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovest.

Explore the full profile